跳至主要内容
临床试验/IRCT2014101019222N2
IRCT2014101019222N2已完成3 期

Effect of the 17 alpha hydroxy progesterone caproate in prevention of preterm labour in high risk pregnant women

Kurdestan University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • single gestation; history of preterm labour before 37 week; history of preterm birth; history of preterm labour in sister;congenital or acquired uterine anomalies; age>18 and <45.
  • Exclusion criteria: Hypertension; cancer; epilepsy; thromboembolic disease; asthma; age<18 and >45; IUGR; vaginal bleeding; PROM; cervical dilation>2cm; fetal major anomalies; progesterone sensitivity; not to follow up the patients; twin pregnancy; tocolytic contraindications; uterine contraction; diabetes; history of cerclage; shortening of cervix.

排除标准

  • 未提供

研究者

发起方
Kurdestan University of Medical Sciences

相似试验